Outpatient Parenteral Antibiotic Therapy (OPAT) Conference & Workshops

Part of the BSAC OPAT Initiative

NATIONAL OPAT CONFERENCE 2022

A hybrid event held on 4 November 2022
ROYAL COLLEGE OF PHYSICIANS, LONDON & ONLINE

A GLOBAL OVERVIEW OF DRUG DEVELOPMENT AND EFFECTIVE USE THROUGH DIAGNOSTICS, STEWARDSHIP AND SHARED LEARNING

This hybrid event was held in London and online 4 November 2022 and is relevant to all healthcare professionals who are involved with the OPAT patient pathway.

You can still register to view the recorded content here. Programme and registration details below.

This hybrid conference is RCPath CPD accredited.

To view the posters presented at this conference, please click here.

Programme

0830
Registration & coffee
0925
Welcome & introduction
Andrew Seaton, Consultant in Infectious Diseases and General Medicine, NHS Greater Glasgow and Clyde - View Bio

SESSION ONE: OPAT - where are we now?
Chair: Sally Tipping, Specialist Antimicrobial Pharmacist, Royal Devon & Exeter Hospital
0930
BSAC OPAT Strategy & Key achievements in 2021/22
Mark Gilchrist, Consultant Pharmacist Infectious Diseases, Imperial College Healthcare NHS Trust - View Bio
0945
Setting the standard for OPAT in Scotland
Andrew Seaton, Consultant in Infectious Diseases and General Medicine, NHS Greater Glasgow and Clyde - View Bio
1000
NHS England – taking a strategic approach to OPAT
Conor Jamieson, Regional Antimicrobial Stewardship Lead Midlands Region, NHS England - View Bio
1015
OPAT developments in Paediatrics
Sanjay Patel, Consultant in Paediatric Infectious Diseases and Immunology, Southampton Children’s Hospital - View Bio
1030
Panel discussion: How can we share successes to work better together?

1045
COFFEE BREAK, EXHIBITION & POSTERS

SESSION TWO: Innovations in OPAT/ COPAT drug delivery
Chair: Andrew Seaton, Consultant in Infectious Diseases and General Medicine, NHS Greater Glasgow and Clyde
1115
Aciclovir in elastomerics - It is now possible?
Fekade Sime, NHMRC Emerging Leadership Fellow, University of Queensland Centre for Clinical Research - View Bio
1135
Probenecid and beta lactams in OPAT/CoPAT - New Zealand experience
Richard Everts, Infectious Diseases Specialist, Nelson Bays Primary Health, New Zealand - View Bio
1155
One size does not fit all in COPAT - practical considerations
Lee Stewart, Antimicrobials Pharmacist, South Glasgow Hospitals - View Bio
1215
OPAT vs COpAT outcomes
Peter McKee, Antimicrobial Pharmacist, Southern Health and Social Care Trust, Craigavon Area Hospital - View Bio
1230
Q&A

SESSION THREE
Supported by: Baxter
1250
Every patient who could have OPAT, should have OPAT – one year on
Katie Holgate, York and Scarborough Hospitals - View Bio
Hannah Bolton, York and Scarborough Hospitals - View Bio

1315
LUNCH BREAK, EXHBITION & POSTERS

SESSION FOUR: Clinical case studies - Invited papers from OPAT Regional Workshops & abstracts
Chair: Sanjay Patel, Consultant in Paediatric Infectious Diseases and Immunology, Southampton Children’s Hospital
1415
Life prolongation at what cost…..An OPAT story
Carolyn Hemsley, Infectious Diseases and Microbiology Consultant, Guy’s & St Thomas’ NHS Foundation - View Bio
1435
OPAT and the vulnerable adult
Meghan Perry, Consultant Physician and Honorary Senior Clinical Lecturer in Infectious Diseases and General Internal Medicine, Western General Hospital, Edinburgh - View Bio
1455
Use of Charlson Comorbidity Index to Predict Risk of Readmission for OPAT Patients: A Quality Improvement Project
Ryan Stubbs, Medical Student, University of Manchester - View Bio
1510
Q&A

SESSION FIVE: Patient selection for outpatient treatment with oritavancin▼
View Prescribing Information and AE reporting
Supported by: Menarini
1535
Hisham Ziglam
Consultant in Infection, Antimicrobial Stewardship Lead, East Lancashire Hospitals NHS Trust, Royal Blackburn Teaching Hospital - View Bio

1600
COFFEE BREAK, EXHIBITION & POSTERS

SESSION SIX: International OPAT
Chair: Mark Gilchrist, Consultant Pharmacist Infectious Diseases, Imperial College Healthcare NHS Trust
1630
Overview of OPAT within Europe
Caroline Emilie, Hospital Infectious Diseases & Infection Prevention and Control Specialist, Nancy Regional University Hospital, France - View Bio
1650
Overview of OPAT within USA
Monica Mahoney, Clinical Pharmacy Specialist, Infectious Diseases Outpatient ID/OPAT Clinics, Beth Israel Deaconess Medical Center, Boston, USA - View Bio
1710
Q&A

1725
Closing remarks
Mark Gilchrist, Consultant Pharmacist Infectious Diseases, Imperial College Healthcare NHS Trust - View Bio

Registration

Please register using the links below and for any questions, please contact Esme Carruthers.

BSAC Membership is FREE! Join here

BSAC Members (NHS/not for profit) £80
Register

Non-members (NHS/not for profit) £100
Register

Commercial £200
Register

Student & LMIC concessions £25
Register

Abstract Submission

Abstract submission is now closed

Top